HALEOSLABSNSEHALEOS LABS LIMITEDMediumNeutral
Announced Mon, 30 Jun · 15:49 IST

SMS Lifesciences India Limited has informed the Exchange regarding Notice of Postal Ballot

Board & Shareholder Meetings View source PDF

HALEOSLABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

SMS Lifesciences India Limited has initiated a Postal Ballot (remote e-voting only) for shareholders to vote on six resolutions. Key items include: (1) Change of company name from 'SMS Lifesciences India Limited' to 'Haleos Labs Limited' with corresponding changes to MoA/AoA — this proposal was earlier approved in Feb 2025, deferred in April 2025, and is now being reinstated; (2) Reappointment of Mr. TV Praveen as Executive Director for 3 years from 1 September 2025 at ₹7.5 lakh/month plus HRA and perquisites; (3) Increase in individual managerial remuneration limit for any Executive Director from 5% to 8% of net profits under Section 197; (4) Overall managerial remuneration approval for three directors totalling ₹3.3 crore annually (Mr. TVVSN Murthy: ₹1.98 cr, Mr. TV Praveen: ₹1.08 cr, Mrs. Sudeepthi Gopineedi: ₹24 lakh), with a ₹4 crore cap if profits are inadequate; (5) & (6) Approval of material related party transactions for FY2025-26 for the company and its material subsidiary. E-voting runs from 1 July 2025 (9:00 AM) to 30 July 2025 (5:00 PM), with results declared on 1 August 2025.

Likely market impact

Shareholders should review and vote on these resolutions, which include a rebranding move (name change does not affect share certificates or shareholder rights), continuation of key management, expanded executive pay limits, and routine RPT approvals. Approval of the name change will alter the company's listed identity; rejection of remuneration proposals could constrain compensation flexibility. No immediate price impact is expected as these are governance/routine approvals.